US President Trump reportedly planning to fire FDA commissioner Makary, WSJ reports

The reported move by President Trump to fire FDA Commissioner Makary may heighten uncertainty around U.S. regulatory policies, especially in the healthcare sector. This could spark volatility across equities and related commodities, as investors assess potential shifts in drug approval processes and public health interventions. Keep an eye on health stocks, USD dynamics, and broader market sentiment as this story develops.